MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Clinical features"

  • 2024 International Congress

    Ultrasound Assessment of Collagen Content in Contracted and Non-contracted Muscle Areas: A Comparative Study

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The objective of this study was to evaluate the feasibility and reliability of ultrasound imaging as a method to estimate collagen content in contracted…
  • 2024 International Congress

    Mutation of the ATP5F1A gene associated with dystonia, spasticity, myoclonus, cognitive impairment and epilepsy – a rare case report of a patient

    M. Danis, G. Krastev, J. Necpal, R. Jech, M. Zech (Trnava, Slovakia)

    Objective: We present a patient with generalized dystonia with spasticity, craniofacial dysmorphism and myoclonus on the left upper limb due to mutation of the ATP5F1A…
  • 2024 International Congress

    Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy

    HJ. Kim, HJ. Ha, CY. Lee, JY. Yun (Seoul, Republic of Korea)

    Objective: Introduction: Leukodystrophies are primarily known as childhood diseases, but recent advances in genetic testing and brain imaging have led to an increase in reports…
  • 2024 International Congress

    Phenotypic spectrum and natural history of POLR3A-associated spastic ataxia

    E. Jung, J. Infante, S. Satolli, F. Santorelli, M. Minnerop, S. Klebe, B. Warrenburg, J. Muñoz, A. Fellner, J. de Winter, A. O'Connor, J. Baets, S. Murphy, M. Ruiz Sales, A. Pujol Onofre, L. Ruggiero, G. Coarelli, A. Dürr, X. Kobeleva, C. Stendel, T. Klopstock, F. Nicita, E. Bertini, Q. Thomas, Y. Goldberg, E. Kogan, L. Basel-Salmon, A. Lossos, Z. Argov, A. de Munain, L. Schöls, R. Schüle (Heidelberg, Germany)

    Objective: To foster trial-readiness, we delineate the full phenotypic spectrum and provide piloting longitudinal natural progression data of POLR3A-associated spastic ataxia in a large international cohort.…
  • 2023 International Congress

    Using wearable wireless technology to understand the natural history of adrenomyeloneuropathy in both clinic and home settings: 1-year follow-up in the CYGNET study

    C. Bergner, W. Koehler, J. Bonkowsky, C. Stephen, F. Eichler, L. Glenn, M. Engelen (Leipzig, Germany)

    Objective: To assess the feasibility of using wearable wireless motion sensors to quantify disease progression in men with adrenomyeloneuropathy (AMN) enrolled in the CYGNET natural…
  • 2023 International Congress

    Quantitative analysis of speech diadochokinetic rate in hereditary spastic paraplegia SPG3A

    V. Agrimaki, S. Siriopoulou, E. Zamba Papanicolaou, K. Christodoulou, K. Konstantopoulos (Kalamata, Greece)

    Objective: To analyze the dysarthria and speech diadochokinetic rate in a patient with hereditary spastic paraplegia (SPG3A). Background: Hereditary spastic paraplegias (HSP) are about 80…
  • 2023 International Congress

    Preparing for a clinical trial: a run-in natural history study in POLR3A-associated spastic ataxia with intronic mutations amenable to splice-modulating therapeutic approaches

    E. Jung, K. Manibarathi, I. Harting, S. Wolf, A. Aartsma-Rus, W. van Roon-Mom, M. Synofzik, H. Graessner, R. Schüle (Heidelberg, Germany)

    Objective: The aim of this study is the identification of progression and treatment response outcomes for POLR3A-associated spastic ataxia caused by the recurrent intronic c.1909+22G>A…
  • 2023 International Congress

    Early-onset spastic ataxia in a patient with prion (PRNP) p.Val180Ile mutation

    SM. Lee, DY. Yoo, TB. Ahn (Seoul, Republic of Korea)

    Objective: To broaden the clinical manifestation of PRNP gene mutation-related ataxia. Background: Genetic forms of prion diseases caused by PRNP mutation account for about 10-15%,…
  • 2023 International Congress

    Clinical and genetic characteristics of a cohort of 20 patients with confirmed biallelic pathogenic SPG7 mutations from the North West of England

    R. Heartshorne, J. Proudfoot-Jones, A. Barakat, M. Bonello (Liverpool, United Kingdom)

    Objective: To identify the prevalence and phenotype of patients with biallelic pathogenic SPG7 mutations Background: Spastic Paraplegia Type 7 (SPG7) is an autosomal recessive disorder…
  • 2023 International Congress

    Expanding the spectrum of Hereditary Spastic Paraplegia: An interesting Case .

    D. Joshi, S. Pattanayak, S. Parida, A. Kumar (Varanasi, India)

    Objective: We describe an interesting case of a young adult with a 5 year progressive history of spastic quadripareisis , cognitive decline, seizures and pseudobulbar…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29077 (not found)
  • #29056 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28189 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley